{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:38:41Z","timestamp":1793119121835,"version":"4.5.0"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","award":["10.13039\/100009945"],"award-info":[{"award-number":["10.13039\/100009945"]}],"id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,12,11]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study aimed to investigate if maternal pregnancy exposure to metformin is associated with increased risk of long-term and short-term adverse outcomes in the child.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods\u202f<\/jats:title>\n                    <jats:p>This register-based cohort study from Finland included singleton children born 2004\u20132016 with maternal pregnancy exposure to metformin or insulin (excluding maternal type 1 diabetes): metformin only (n=3967), insulin only (n=5273) and combination treatment (metformin and insulin; n=889). The primary outcomes were long-term offspring obesity, hypoglycemia, hyperglycemia, diabetes, hypertension, polycystic ovary syndrome, and challenges in motor\u2013social development. In a sensitivity analysis, the primary outcomes were investigated only among children with maternal gestational diabetes. Secondary outcomes were adverse outcomes at birth. Analyses were conducted using inverse- probability of treatment weighting (IPTW), with insulin as reference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results\u202f\u202f<\/jats:title>\n                    <jats:p>Exposure to metformin or combination treatment versus insulin was not associated with increased risk of long-term outcomes in the main or sensitivity analyses. Among the secondary outcomes, increased risk of small for gestational age (SGA) was observed for metformin (IPTW-weighted OR 1.65, 95% CI 1.16 to 2.34); increased risk of large for gestational age, preterm birth and hypoglycemia was observed for combination treatment. No increased risk was observed for neonatal mortality, hyperglycemia, or major congenital anomalies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\u202f<\/jats:title>\n                    <jats:p>This study found no increased long-term risk associated with pregnancy exposure to metformin (alone or in combination with insulin), compared with insulin. The increased risk of SGA associated with metformin versus insulin suggests caution in pregnancies with at-risk fetal undernutrition. The increased risks of adverse outcomes at birth associated with combination treatment may reflect confounding by indication or severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2021-002363","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:50:35Z","timestamp":1641383435000},"page":"e002363","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":68,"title":["Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8374-4026","authenticated-orcid":false,"given":"Kerstin M G","family":"Brand","sequence":"first","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Saarelainen","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaak","family":"Sonajalg","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Tartu, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Boutmy","sequence":"additional","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-5560","authenticated-orcid":false,"given":"Caroline","family":"Foch","sequence":"additional","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"V\u00e4\u00e4r\u00e4sm\u00e4ki","sequence":"additional","affiliation":[{"name":"PEDEGO Research Unit, Medical Research Centre Oulu, Oulu University Hospital, Oulu, Finland"},{"name":"University of Oulu, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Morin-Papunen","sequence":"additional","affiliation":[{"name":"PEDEGO Research Unit, Medical Research Centre Oulu, Oulu University Hospital, Oulu, Finland"},{"name":"University of Oulu, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Schlachter","sequence":"additional","affiliation":[{"name":"Merck KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CLUE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M","family":"Hakkarainen","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Korhonen","sequence":"additional","affiliation":[{"name":"Global Database Studies, IQVIA, Espoo, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"2025073111411570000_10.1.e002363.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S009"},{"key":"2025073111411570000_10.1.e002363.2","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0066"},{"key":"2025073111411570000_10.1.e002363.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000759"},{"key":"2025073111411570000_10.1.e002363.4","unstructured":"Finnish Medical Society Duodecim . Raskausdiabetes: K\u00e4yp\u00e4 hoito -suositus [in Finnish], 2013. Available: http:\/\/www.kaypahoito.fi\/web\/kh\/suositukset\/suositus?id=hoi50068 [Accessed 22 Jan 2021]."},{"key":"2025073111411570000_10.1.e002363.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1045"},{"key":"2025073111411570000_10.1.e002363.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2090"},{"key":"2025073111411570000_10.1.e002363.7","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.5.1390"},{"key":"2025073111411570000_10.1.e002363.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1053-0"},{"key":"2025073111411570000_10.1.e002363.9","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13150"},{"key":"2025073111411570000_10.1.e002363.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707193"},{"key":"2025073111411570000_10.1.e002363.11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.reprotox.2018.05.007","article-title":"In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: a prospective comparative observational study","volume":"80","author":"Diav-Citrin","year":"2018","journal-title":"Reprod Toxicol"},{"key":"2025073111411570000_10.1.e002363.12","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13481"},{"key":"2025073111411570000_10.1.e002363.13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.reprotox.2018.07.004","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a prospective cohort study","volume":"81","author":"Scherneck","year":"2018","journal-title":"Reprod Toxicol"},{"key":"2025073111411570000_10.1.e002363.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02763.x"},{"key":"2025073111411570000_10.1.e002363.15","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12964"},{"key":"2025073111411570000_10.1.e002363.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000456"},{"key":"2025073111411570000_10.1.e002363.17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1900\/RDS.2016.13.59","article-title":"Metformin treatment does not affect testicular size in offspring born to mothers with gestational diabetes","volume":"13","author":"Tertti","year":"2016","journal-title":"Rev Diabet Stud"},{"key":"2025073111411570000_10.1.e002363.18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamapediatrics.2018.4214","article-title":"Association of long-term child growth and developmental outcomes with metformin vs insulin treatment for gestational diabetes","volume":"173","author":"Landi","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2025073111411570000_10.1.e002363.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0853"},{"key":"2025073111411570000_10.1.e002363.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02419"},{"key":"2025073111411570000_10.1.e002363.21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","article-title":"Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial","volume":"3","author":"Hanem","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"2025073111411570000_10.1.e002363.22","doi-asserted-by":"crossref","first-page":"246.e1","DOI":"10.1016\/j.ajog.2020.01.054","article-title":"Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring","volume":"223","author":"Panagiotopoulou","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2025073111411570000_10.1.e002363.23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/DBP.0000000000000230","article-title":"Neurodevelopment of two-year-old children exposed to metformin and insulin in gestational diabetes mellitus","volume":"36","author":"Tertti","year":"2015","journal-title":"J Dev Behav Pediatr"},{"key":"2025073111411570000_10.1.e002363.24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111411570000_10.1.e002363.25","unstructured":"Finnish Institute for Health and Welfare . Medical birth register: quality description, 2018. Available: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics\/information-on-statistics\/quality-descriptions\/parturients-delivers-and-newborns [Accessed 18 Feb 2020]."},{"key":"2025073111411570000_10.1.e002363.26","unstructured":"Social Insurance Institution . Finnish Prescription Register: Quality description 2019. (In Finnish: Laatuseloste 2019: Tilasto korvatuista resepteist\u00e4) [in Finnish], 2019. Available: http:\/\/www.kela.fi\/laatuseloste-2015-tilasto-korvatuista-resepteista#4 [Accessed 18 Feb 2020]."},{"key":"2025073111411570000_10.1.e002363.27","unstructured":"Care Register for Health Care - THL. Finnish Institute for Health and Welfare (THL), Finland. Available: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics\/information-on-statistics\/register-descriptions\/care-register-for-health-care [Accessed 04 Jun 2020]."},{"key":"2025073111411570000_10.1.e002363.28","unstructured":"Register of primary health care visits - THL. Finnish Institute for Health and Welfare (THL), Finland. Available: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics\/information-on-statistics\/register-descriptions\/register-of-primary-health-care-visits [Accessed 04 Jun 2020]."},{"key":"2025073111411570000_10.1.e002363.29","unstructured":"Finnish Institute for Health and Welfare . Congenital anomalies: quality description, 2018. Available: http:\/\/thl.fi:8080\/en\/web\/thlfi-en\/statistics\/information-on-statistics\/quality-descriptions\/congenital-anomalies [Accessed 31 Jan 2020]."},{"key":"2025073111411570000_10.1.e002363.30","unstructured":"EUROCAT . EUROCAT guide 1.4, 2018. Available: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/data-collection\/guidelines-for-data-registration [Accessed 30 Jan 2020]."},{"key":"2025073111411570000_10.1.e002363.31","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12197"},{"key":"2025073111411570000_10.1.e002363.32","unstructured":"Eu PAS register: consequences for life of children with in utero exposure to metformin in Finland \u2013 a register-based cohort study (EUPAS19686), 2019. Available: http:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=31566 [Accessed 22 Oct 2020]."},{"key":"2025073111411570000_10.1.e002363.33","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2012.712319"},{"key":"2025073111411570000_10.1.e002363.34","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1542\/pir.20.7.e6","article-title":"Neonatal hypoglycemia","volume":"20","author":"McGowan","year":"1999","journal-title":"Pediatrics In Review"},{"key":"2025073111411570000_10.1.e002363.35","unstructured":"Yadav D , Hypoglycemia PN . Hypoglycemia - Causes and Occurrences. Dover, DE, USA: SMGroup, 2016: 1\u201315."},{"key":"2025073111411570000_10.1.e002363.36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256"},{"key":"2025073111411570000_10.1.e002363.37","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2008.5.95"},{"key":"2025073111411570000_10.1.e002363.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509819"},{"key":"2025073111411570000_10.1.e002363.39","doi-asserted-by":"crossref","first-page":"S554","DOI":"10.1016\/j.ajog.2019.11.902","article-title":"890: best gestational diabetes therapy to reduce adverse maternal outcomes. A network meta-analysis","volume":"222","author":"Mateus","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2025073111411570000_10.1.e002363.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002848","article-title":"Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis","volume":"16","author":"Tarry-Adkins","year":"2019","journal-title":"PLoS Med"},{"key":"2025073111411570000_10.1.e002363.41","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1670804"},{"key":"2025073111411570000_10.1.e002363.42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.obmed.2018.08.001","article-title":"Metformin versus insulin for gestational diabetes: the reporting of ethnicity and a meta-analysis combining English and Chinese literatures","volume":"11","author":"Zhen","year":"2018","journal-title":"Obes Med"},{"key":"2025073111411570000_10.1.e002363.43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"L\u00f8vvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025073111411570000_10.1.e002363.44","unstructured":"Kjerpeseth L , Cesta C , Engeland A . Risk of major congenital malformations with metformin compared with insulin in pregnancy. EASD 2020 https:\/\/www.easd.org\/virtualmeeting\/home.html#!resources\/risk-of-major-congenital-malformations-with-metformin-compared-with-insulin-in-pregnancy-34eb45fc-47e3-499d-b1f7-d711c408c2c9"},{"key":"2025073111411570000_10.1.e002363.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-020-03207-0","article-title":"Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025073111411570000_10.1.e002363.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2477"},{"key":"2025073111411570000_10.1.e002363.47","doi-asserted-by":"publisher","DOI":"10.1177\/1403494812456637"},{"key":"2025073111411570000_10.1.e002363.48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/bfm.2020.0321","article-title":"Breastfeeding success among women with gestational diabetes managed by diet only compared with those requiring medications","volume":"16","author":"Kole-White","year":"2021","journal-title":"Breastfeed Med"},{"key":"2025073111411570000_10.1.e002363.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.01.011"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:41:28Z","timestamp":1753987288000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,5]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjdrc-2021-002363"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002363","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}